<html>
<head>PUBMED IDs for CDK3</head>
<body bgcolor='#C5F0F2'><h1>CDK3</h1><a href='https://pubmed.ncbi.nlm.nih.gov/8626584/'>Suppression of apoptosis by dominant negative mutants of cyclin-dependent protein kinases.</a> April 26  1996<br><a href='https://pubmed.ncbi.nlm.nih.gov/9778038/'>Deregulated expression of CDK2- or CDK3-associated kinase activities enhances c-Myc-induced apoptosis.</a> October 20  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/9840943/'>Cyclin E2, a novel human G1 cyclin and activating partner of CDK2 and CDK3, is induced by viral oncoproteins.</a> December 5  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/9858813/'>Molecular cytogenetic mapping of 24 CEPH YACs and 24 gene-specific large insert probes to chromosome 17.</a> December 22  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/9858811/'>Mouse centromere protein F (Cenpf) gene maps to the distal region of chromosome 1 by interspecific backcross analysis.</a> December 22  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/10634406/'>High expression of cyclin E and G1 CDK and loss of function of p57KIP2 are involved in proliferation of malignant sporadic adrenocortical tumors.</a> January 14  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11172011/'>A premature-termination mutation in the Mus musculus cyclin-dependent kinase 3 gene.</a> February 15  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/12025230/'>Effects of interferon alpha on the expression of p21cip1/waf1 and cell cycle distribution in carcinoid tumors.</a> May 25  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/14534694/'>Expression of cell cycle/growth regulator genes in human hepatocellular carcinoma and adjacent normal liver tissues.</a> October 10  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/19237534/'>Phosphorylation by cyclin C/cyclin-dependent kinase 2 following mitogenic stimulation of murine fibroblasts inhibits transcriptional activity of LSF during G1 progression.</a> May 9  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/21223249/'>Molecular and cellular effects of multi-targeted cyclin-dependent kinase inhibition in myeloma: biological and clinical implications.</a> April 1  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22552300/'>Identification of a GαGβγ, AKT and PKCα signalome associated with invasive growth in two genetic models of human breast cancer cell epithelial-to-mesenchymal transition.</a> September 1  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23236518/'>Distinct expression pattern and post-transcriptional regulation of cell cycle genes in the glandular epithelia of avian ovarian carcinomas.</a> June 12  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23707792/'>Expression profiling of cell cycle genes in human pancreatic islets with and without type 2 diabetes.</a> February 5  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24691537/'>CDK3 expression and its clinical significance in human nasopharyngeal carcinoma.</a> January 6  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25344755/'>Cyclin C is a haploinsufficient tumour suppressor.</a> January 30  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25531331/'>MiR-873 regulates ERα transcriptional activity and tamoxifen resistance via targeting CDK3 in breast cancer cells.</a> October 10  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26980484/'>Competing endogenous RNA networks of CYP4Z1 and pseudogene CYP4Z2P confer tamoxifen resistance in breast cancer.</a> January 7  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28533356/'>Loss-of-function mutations in the CABLES1 gene are a novel cause of Cushing's disease.</a> May 24  2017<br></body></html>
